Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1491-1500 of 3399 for cancer

Edit search filters
  1. A Study to Evaluate AFPᶜ³³²T in Advanced HCC

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Trial To Evaluate Multiple Regimens In Newly Diagnosed And Recurrent Glioblastoma

    Jacksonville, FL, Rochester, MN

  3. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Rochester, MN

  4. A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

    Rochester, MN

  5. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS

    Rochester, MN

  6. Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes

    Rochester, MN

  7. A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene

    Scottsdale/Phoenix, AZ

  8. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  9. Embolization Before Ablation Of Renal Cell Carcinoma (EMBARC)"

    Rochester, MN

  10. Investigating Magnesium Glycinate In Structure/Function Role Of Hot Flashes.

    Jacksonville, FL

.

Mayo Clinic Footer